AGIO logo

Agios Pharmaceuticals (AGIO)

Profile

Full Name

Agios Pharmaceuticals, Inc.

Ticker Symbol

AGIO

Exchange

NASDAQ

Country

United States

IPO

July 24, 2013

Indexes

Not included

Employees

486

Key Details

Price

$28.97

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$36.50M(+36.07% YoY)

Annual EPS

$11.64(+283.89% YoY)

PE Ratio

2.55

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 24, 25 HC Wainwright & Co.
Buy
Dec 18, 24 Cantor Fitzgerald
Overweight
Dec 10, 24 RBC Capital
Outperform
Dec 9, 24 Scotiabank
Sector Outperform
Nov 1, 24 Scotiabank
Sector Outperform
Oct 16, 24 Scotiabank
Sector Outperform
Sep 27, 24 Leerink Partners
Market Perform
Sep 20, 24 Cantor Fitzgerald
Overweight
Sep 19, 24 RBC Capital
Outperform
Aug 2, 24 RBC Capital
Outperform

Institutional Ownership

  • What is the ticker symbol for Agios Pharmaceuticals?
  • Does Agios Pharmaceuticals pay dividends?
  • What sector is Agios Pharmaceuticals in?
  • What industry is Agios Pharmaceuticals in?
  • What country is Agios Pharmaceuticals based in?
  • When did Agios Pharmaceuticals go public?
  • Is Agios Pharmaceuticals in the S&P 500?
  • Is Agios Pharmaceuticals in the NASDAQ 100?
  • Is Agios Pharmaceuticals in the Dow Jones?
  • When was Agios Pharmaceuticals's last earnings report?
  • When does Agios Pharmaceuticals report earnings?
  • Should I buy Agios Pharmaceuticals stock now?

What is the ticker symbol for Agios Pharmaceuticals?

The ticker symbol for Agios Pharmaceuticals is NASDAQ:AGIO

Does Agios Pharmaceuticals pay dividends?

No, Agios Pharmaceuticals does not pay dividends

What sector is Agios Pharmaceuticals in?

Agios Pharmaceuticals is in the Healthcare sector

What industry is Agios Pharmaceuticals in?

Agios Pharmaceuticals is in the Biotechnology industry

What country is Agios Pharmaceuticals based in?

Agios Pharmaceuticals is headquartered in United States

When did Agios Pharmaceuticals go public?

Agios Pharmaceuticals's initial public offering (IPO) was on July 24, 2013

Is Agios Pharmaceuticals in the S&P 500?

No, Agios Pharmaceuticals is not included in the S&P 500 index

Is Agios Pharmaceuticals in the NASDAQ 100?

No, Agios Pharmaceuticals is not included in the NASDAQ 100 index

Is Agios Pharmaceuticals in the Dow Jones?

No, Agios Pharmaceuticals is not included in the Dow Jones index

When was Agios Pharmaceuticals's last earnings report?

Agios Pharmaceuticals's most recent earnings report was on Feb 13, 2025

When does Agios Pharmaceuticals report earnings?

The next expected earnings date for Agios Pharmaceuticals is May 2, 2025

Should I buy Agios Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page